$MDAI
Spectral AI, Inc.

2023 Q4 Form 10-Q Financial Statement

#000121390023086995 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q4
Revenue $5.287M $3.440M $0.00
YoY Change
Cost Of Revenue $2.851M $1.968M
YoY Change -48.36%
Gross Profit $2.436M $1.472M
YoY Change -54.38%
Gross Profit Margin 46.08% 42.79%
Selling, General & Admin $5.365M $5.638M $300.1K
YoY Change 1687.62% 2278.2% -83.17%
% of Gross Profit 220.24% 383.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $2.000K $7.000K
YoY Change
% of Gross Profit 0.08% 0.48%
Operating Expenses $5.365M $5.638M $300.1K
YoY Change 1687.62% 2278.2% -83.17%
Operating Profit -$2.929M -$4.166M
YoY Change 1657.28%
Interest Expense $31.00K $18.00K $2.003M
YoY Change -98.45% -98.91% -168.81%
% of Operating Profit
Other Income/Expense, Net -$669.0K -$6.517M $0.00
YoY Change
Pretax Income -$3.567M -$10.68M $1.703M
YoY Change -309.44% -857.16% -136.28%
Income Tax -$21.00K -$54.00K $362.5K
% Of Pretax Income 21.29%
Net Earnings -$3.546M -$10.63M $1.341M
YoY Change -364.51% -996.45% -128.56%
Net Earnings / Revenue -67.07% -308.98%
Basic Earnings Per Share -$0.77
Diluted Earnings Per Share -$0.47 -$0.77 $0.04
COMMON SHARES
Basic Shares Outstanding 16.25M shares 13.82M shares
Diluted Shares Outstanding 13.82M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.790M $7.348M $785.0K
YoY Change 510.16% -97.12% 2.03%
Cash & Equivalents $4.790M $7.348M $785.0K
Short-Term Investments
Other Short-Term Assets $2.536M $594.0K $153.6K
YoY Change 1551.26% 417.06% -50.95%
Inventory $230.0K $220.0K
Prepaid Expenses $1.452M $1.755M $153.6K
Receivables $2.346M $1.312M $2.294M
Other Receivables $0.00 $0.00
Total Short-Term Assets $9.902M $11.36M $938.6K
YoY Change 954.96% 1694.81% -13.3%
LONG-TERM ASSETS
Property, Plant & Equipment $790.0K $14.00K $21.00K
YoY Change 3661.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $4.626M
YoY Change -98.17%
Other Assets
YoY Change
Total Long-Term Assets $790.0K $975.0K $4.626M
YoY Change -82.92% -99.62% -98.17%
TOTAL ASSETS
Total Short-Term Assets $9.902M $11.36M $938.6K
Total Long-Term Assets $790.0K $975.0K $4.626M
Total Assets $10.69M $12.33M $5.565M
YoY Change 92.14% -95.16% -97.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.683M $3.275M $2.759M
YoY Change -2.75%
Accrued Expenses $3.483M $3.983M $3.352M
YoY Change 3.9% 29.49% 15.25%
Deferred Revenue $2.311M
YoY Change
Short-Term Debt $436.0K $632.0K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.40M $10.65M $3.624M
YoY Change 242.22% 218.41% 23.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $228.0K $9.249M
YoY Change -100.0% -97.64% -51.31%
Total Long-Term Liabilities $0.00 $228.0K $9.249M
YoY Change -100.0% -97.64% -51.31%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.40M $10.65M $3.624M
Total Long-Term Liabilities $0.00 $228.0K $9.249M
Total Liabilities $12.40M $10.88M $12.87M
YoY Change -3.67% -16.26% -41.31%
SHAREHOLDERS EQUITY
Retained Earnings -$32.79M -$29.24M -$12.10M
YoY Change 171.05% 142.2% -41.91%
Common Stock $2.000K $2.000K $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.709M $1.456M -$12.10M
YoY Change
Total Liabilities & Shareholders Equity $10.69M $12.33M $5.565M
YoY Change 92.14% -95.16% -97.81%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q4
OPERATING ACTIVITIES
Net Income -$3.546M -$10.63M $1.341M
YoY Change -364.51% -996.45% -128.56%
Depreciation, Depletion And Amortization $2.000K $7.000K
YoY Change
Cash From Operating Activities -$2.375M -$10.49M -$421.4K
YoY Change 463.61% 19349.08% 346.67%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $251.2M
YoY Change
Cash From Investing Activities $251.2M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -195.0K 4.039M -250.5M
YoY Change -99.92%
NET CHANGE
Cash From Operating Activities -2.375M -10.49M -421.4K
Cash From Investing Activities 251.2M
Cash From Financing Activities -195.0K 4.039M -250.5M
Net Change In Cash -2.570M -6.446M 267.2K
YoY Change -1061.83% -2306.78% -383.23%
FREE CASH FLOW
Cash From Operating Activities -$2.375M -$10.49M -$421.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
346000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
10875000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6720000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
961000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1008000 usd
CY2023Q3 us-gaap Assets
Assets
12331000 usd
CY2022Q4 us-gaap Assets
Assets
18716000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3275000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2759000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3983000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2631000 usd
CY2023Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
795000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
813000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
680000 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
632000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
175000 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1149000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
129000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10647000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6374000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
228000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
SPECTRAL AI, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3987148
dei Entity Address Address Line1
EntityAddressAddressLine1
2515 McKinney Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Suite 1000Dallas
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75201
dei City Area Code
CityAreaCode
(972)
dei Local Phone Number
LocalPhoneNumber
499-4934
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16254935 shares
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7348000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14174000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1312000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2294000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
220000 usd
CY2023Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
127000 usd
CY2022Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
618000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1755000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
331000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
594000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
270000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
11356000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
17687000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21000 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15688268 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15688268 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13127472 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13127472 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30696000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23929000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29242000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11934000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1456000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11996000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12331000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18716000 usd
CY2023Q3 us-gaap Revenues
Revenues
3440000 usd
CY2022Q3 us-gaap Revenues
Revenues
7038000 usd
us-gaap Revenues
Revenues
12769000 usd
us-gaap Revenues
Revenues
19272000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
1968000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
3811000 usd
us-gaap Cost Of Revenue
CostOfRevenue
7325000 usd
us-gaap Cost Of Revenue
CostOfRevenue
10943000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1472000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
3227000 usd
us-gaap Gross Profit
GrossProfit
5444000 usd
us-gaap Gross Profit
GrossProfit
8329000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5638000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3478000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15499000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9207000 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5638000 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3478000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
15499000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
9207000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4166000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-251000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10055000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-878000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
42000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
128000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1069000 usd
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-22000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1004000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-50000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-24000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-51000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-255000 usd
CY2023Q3 mdai Transaction Costs
TransactionCosts
7604000 usd
mdai Transaction Costs
TransactionCosts
8342000 usd
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
17000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6517000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-44000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7221000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-204000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10683000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-295000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17276000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1082000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-54000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
91000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10629000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-380000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17308000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1173000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13822990 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13145834 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13410287 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13127825 shares
CY2022Q4 mdai Temporary Equity Shares Outstanding Before Retroactive Application Of Recapitalizations
TemporaryEquitySharesOutstandingBeforeRetroactiveApplicationOfRecapitalizations
11996000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11996000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
300000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3609000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
8687000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
396000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3070000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
6019000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-2374000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
150000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1800000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
2550000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3351000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
279000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
310000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10629000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1456000 usd
CY2021Q4 mdai Temporary Equity Shares Outstanding Before Retroactive Application Of Recapitalizations
TemporaryEquitySharesOutstandingBeforeRetroactiveApplicationOfRecapitalizations
13753000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13753000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
333000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-528000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
13558000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
294000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-265000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
13587000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
247000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-380000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
13454000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17308000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1173000 usd
us-gaap Depreciation
Depreciation
7000 usd
us-gaap Depreciation
Depreciation
6000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
975000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
874000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-530000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-377000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1800000 usd
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
2550000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1004000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-50000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-982000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
317000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
220000 usd
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-491000 usd
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
1502000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
469000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-753000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
197000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
188000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-554000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
886000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1225000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-76000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
795000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-468000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-453000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10865000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-863000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3351000 usd
mdai Cash Received In Business Combination
CashReceivedInBusinessCombination
-660000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
288000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
651000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
316000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4039000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-651000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6826000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1514000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14174000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16121000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7348000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14607000 usd
us-gaap Interest Paid Net
InterestPaidNet
6000 usd
us-gaap Interest Paid Net
InterestPaidNet
19000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
114000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
53000 usd
mdai Recognition Of Rightofuse Assets And Related Lease Liabilitie Upon Adoption Of Asc842
RecognitionOfRightofuseAssetsAndRelatedLeaseLiabilitieUponAdoptionOfASC842
624000 usd
mdai Recognition Of Rightofuse Assets And Related Lease Liabilities Upon Lease Amendment
RecognitionOfRightofuseAssetsAndRelatedLeaseLiabilitiesUponLeaseAmendment
483000 usd
mdai Issuance Of Common Stock For Net Liabilities Upon Business Combination
IssuanceOfCommonStockForNetLiabilitiesUponBusinessCombination
3034000 usd
mdai Prepaid Asset Acquired Net Of Cancellation For Debt And Accounts Payable
PrepaidAssetAcquiredNetOfCancellationForDebtAndAccountsPayable
955000 usd
mdai Prepaid Asset Acquired Net Of Cancellation For Debt And Accounts Payable
PrepaidAssetAcquiredNetOfCancellationForDebtAndAccountsPayable
376000 usd
mdai Issuance Of Common Stock To Settle Accounts Payable
IssuanceOfCommonStockToSettleAccountsPayable
150000 usd
mdai Common Stock Exchange Ratio Price
CommonStockExchangeRatioPrice
10.31
CY2023Q3 us-gaap Contract Receivable Retainage Due Five Years Or More
ContractReceivableRetainageDueFiveYearsOrMore
149000000 usd
us-gaap Clearance Fees
ClearanceFees
55000000 usd
CY2023Q2 us-gaap Amount Of Regulatory Assistance Received1
AmountOfRegulatoryAssistanceReceived1
4000 usd
CY2023Q3 us-gaap Cash
Cash
7300000 usd
CY2022Q4 us-gaap Cash
Cash
14200000 usd
CY2023Q3 us-gaap Other Additional Capital
OtherAdditionalCapital
149000000 usd
mdai Aggregated Funding Options
AggregatedFundingOptions
250000000 usd
mdai Potential Fund
PotentialFund
101000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b>Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="background-color: white">The preparation of these condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. The Company bases its estimates and judgments on historical experience and on various other assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities reported in the Company’s balance sheets and the amounts of expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but not limited to, revenue recognition, warrant liabilities, stock-based compensation expense, stock issued for transaction costs, the net realizable value of inventory, right-of-use assets and income tax valuation allowances. Actual results could differ from these estimates.</span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b>Concentrations of Credit Risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="background-color: white">Financial instruments which potentially subject the Company to credit risk consist principally of cash and accounts receivable. Primarily all cash is held in US financial institutions which, at times, exceed federally insured limits. The Company has not recognized any losses from credit risks on such accounts. The Company believes it is not exposed to significant credit risk on cash.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="background-color: white">Additional credit risk is related to the Company’s concentration of receivables. As of September 30, 2023 and December 31, 2022, receivables were concentrated from one customer (which is a US. government agency) representing 87% and 96% of total net receivables, respectively. No allowance for doubtful accounts were recorded as of September 30, 2023 and December 31, 2022.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="background-color: white">One customer (which is a U.S. government agency) accounted for 89% and 94% for the three and nine months ended September 30, 2023, respectively, and 98% for each of the three and nine months ended September 30, 2022 of the recognized research and development revenue.</span></p>
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
24000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
11000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
100000 usd
us-gaap Foreign Currency Transaction Gain Before Tax
ForeignCurrencyTransactionGainBeforeTax
300000 usd
CY2023Q3 mdai Noncash Net Assets Assumed In Exchange For Common Stock
NoncashNetAssetsAssumedInExchangeForCommonStock
-3034 usd
us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
33333 usd
CY2023Q3 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
7600000 usd
CY2023Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1400000 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1000000 usd
CY2023Q3 us-gaap Business Combination Acquired Receivables Fair Value
BusinessCombinationAcquiredReceivablesFairValue
1800000 usd
CY2023Q3 us-gaap Shares Held In Employee Stock Option Plan Committed To Be Released
SharesHeldInEmployeeStockOptionPlanCommittedToBeReleased
566667 shares
us-gaap Business Combination Consideration Transferred Liabilities Incurred
BusinessCombinationConsiderationTransferredLiabilitiesIncurred
700000 usd
CY2023Q3 us-gaap Contractual Obligation
ContractualObligation
1300000 usd
mdai Agreement Term
AgreementTerm
P2Y
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
2400000 usd
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
660 usd
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
127 usd
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
860 usd
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
277 usd
CY2023Q3 mdai Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Warrant Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedWarrantLiabilities
-2024 usd
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
-2374 usd
CY2023Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Financial Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialAssets
660 usd
CY2023Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1149000 usd
CY2022Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
129000 usd
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
129000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-16000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
113000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
81000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
194000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-141000 usd
CY2023Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
53000 usd
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
186000 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-66000 usd
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
120000 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
38000 usd
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
158000 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-22000 usd
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
136000 usd
CY2023Q3 us-gaap Revenues
Revenues
3440000 usd
CY2022Q3 us-gaap Revenues
Revenues
7038000 usd
us-gaap Revenues
Revenues
12769000 usd
us-gaap Revenues
Revenues
19272000 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1403000 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1135000 usd
us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
1000000 usd
us-gaap Operating Expenses
OperatingExpenses
619000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
736000 usd
CY2023Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
803000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
650000 usd
CY2023Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
158000 usd
CY2022Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
110000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3983000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2631000 usd
mdai Principal Repayments Insurance Note
PrincipalRepaymentsInsuranceNote
288000 usd
mdai Principal Repayments Insurance Note
PrincipalRepaymentsInsuranceNote
227000 usd
mdai Insurance Note Outstanding Balance
InsuranceNoteOutstandingBalance
632000 usd
CY2022 mdai Insurance Note Outstanding Balance
InsuranceNoteOutstandingBalance
175000 usd
CY2023Q3 us-gaap Notes And Loans Payable
NotesAndLoansPayable
38000 usd
CY2020Q2 us-gaap Notes Payable To Bank Current
NotesPayableToBankCurrent
768575 usd
CY2022Q2 us-gaap Long Term Debt Percentage Bearing Variable Interest Rate
LongTermDebtPercentageBearingVariableInterestRate
0.01 pure
us-gaap Line Of Credit Facility Periodic Payment
LineOfCreditFacilityPeriodicPayment
400000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
853000 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
474000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
41000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
69000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
338000 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
177000 usd
CY2023Q3 us-gaap Lease Incentive Receivable Current
LeaseIncentiveReceivableCurrent
100 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
208000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
159000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
536000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
472000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
483000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
624000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y4M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M18D
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y4M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085 pure
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.085 pure
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.067 pure
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
205000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
132000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
597000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
396000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
92000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
45000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
256000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
78000 usd
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
297000 usd
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
177000 usd
us-gaap Lease Cost
LeaseCost
922000 usd
us-gaap Lease Cost
LeaseCost
474000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
208000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
894000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1102000 usd
CY2023Q3 us-gaap Receivable With Imputed Interest Net Amount
ReceivableWithImputedInterestNetAmount
61000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1041000 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
30318 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
30318 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
58197 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.65
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
58197 shares
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
4.65
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.288 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.084 pure
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
4.68
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.72 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.036 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3503790 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.06
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6831000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
253250 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
15844 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.68
mdai Mdai Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
mdai_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
-20368 shares
mdai Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Prices
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrices
1.95
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
126247 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.16
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3594581 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.22
mdai Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term3
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm3
P6Y9M18D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2823000 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
2847580 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
2752000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
200000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y2M12D
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.005 pure
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4519195 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4418871 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8507311 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
73978 shares
CY2023Q3 mdai Unvested Restricted Stock Units
UnvestedRestrictedStockUnits
58197 shares
CY2022Q3 mdai Unvested Restricted Stock
UnvestedRestrictedStock
54566 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13084703 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4547415 shares
CY2023Q4 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
8000000 shares
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
usd
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2022Q3 mdai Transaction Costs
TransactionCosts
usd
mdai Transaction Costs
TransactionCosts
usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13127825 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13145834 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13410287 shares
CY2022Q4 mdai Temporary Equity Retroactive Application Of Recapitalizations
TemporaryEquityRetroactiveApplicationOfRecapitalizations
usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
CY2021Q4 mdai Temporary Equity Retroactive Application Of Recapitalizations
TemporaryEquityRetroactiveApplicationOfRecapitalizations
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
mdai Cash Received In Business Combination
CashReceivedInBusinessCombination
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
mdai Recognition Of Rightofuse Assets And Related Lease Liabilitie Upon Adoption Of Asc842
RecognitionOfRightofuseAssetsAndRelatedLeaseLiabilitieUponAdoptionOfASC842
usd
mdai Recognition Of Rightofuse Assets And Related Lease Liabilities Upon Lease Amendment
RecognitionOfRightofuseAssetsAndRelatedLeaseLiabilitiesUponLeaseAmendment
usd
mdai Issuance Of Common Stock For Net Liabilities Upon Business Combination
IssuanceOfCommonStockForNetLiabilitiesUponBusinessCombination
usd
mdai Issuance Of Common Stock To Settle Accounts Payable
IssuanceOfCommonStockToSettleAccountsPayable
usd
CY2022 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
usd
CY2023Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
shares
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022Q3 mdai Unvested Restricted Stock Units
UnvestedRestrictedStockUnits
shares
CY2023Q3 mdai Unvested Restricted Stock
UnvestedRestrictedStock
shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001833498
dei Entity File Number
EntityFileNumber
00-0000000

Files In Submission

Name View Source Status
mdai-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001213900-23-086995-index-headers.html Edgar Link pending
0001213900-23-086995-index.html Edgar Link pending
0001213900-23-086995.txt Edgar Link pending
0001213900-23-086995-xbrl.zip Edgar Link pending
ex10-1_001.jpg Edgar Link pending
ex10-1_002.jpg Edgar Link pending
f10q0923ex10-1_spectral.htm Edgar Link pending
f10q0923ex31-1_spectral.htm Edgar Link pending
f10q0923ex31-2_spectral.htm Edgar Link pending
f10q0923ex32_spectral.htm Edgar Link pending
f10q0923_spectral.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mdai-20230930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
mdai-20230930_pre.xml Edgar Link unprocessable
mdai-20230930_def.xml Edgar Link unprocessable
mdai-20230930_lab.xml Edgar Link unprocessable
f10q0923_spectral_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending